TSC22D3 Antibody (YA8097)
(Synonyms: DIP; DSIPI; GILZ; TSC-22R)TSC22D3 Antibody (YA8097) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to TSC22D3.
-
Host:
Mouse
-
Isotype:
IgG2b
-
Application:
ICC/IF
-
Reactivity :
Human, Mouse
-
Formulation:
Spplied in PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
-
Conjugation:
Non-conjugated
Applications
| Application |
ICC/IF
ICC/IF: Immunocytochemistry/
Immunofluorescence |
|---|---|
| Dilution Ratio | 1:100-250 |
Product Details
TSC22D3 Antibody (YA8097) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to TSC22D3.
-
Host Mouse
-
Clonality Monoclonal
-
Species ReactivityHuman, Mouse
-
Calculated Molecular Weight Predicted band size: 14.6 kDa
Full length human recombinant protein of human TSC22D3 produced in HEK293T cell.
Endogenous
Affinity purified
Non-conjugated
Unmodified
IgG2b
Product Properties
-
Appearance
Liquid
-
Formulation
Spplied in PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Background
-
Function
TSC22D3 protects T-cells from IL2 deprivation-induced apoptosis through the inhibition of FOXO3A transcriptional activity that leads to the down-regulation of the pro-apoptotic factor BCL2L11. In macrophages, plays a role in the anti-inflammatory and immunosuppressive effects of glucocorticoids and IL10. In T-cells, inhibits anti-CD3-induced NFKB1 nuclear translocation and thereby NFKB1 DNA-binding activities. In vitro, suppresses AP-1 transcription factor complex DNA-binding activities|Inhibits myogenic differentiation and mediates anti-myogenic effects of glucocorticoids by binding and regulating MYOD1 and HDAC1 transcriptional activity resulting in reduced expression of MYOG[1][2][3].
-
Subcellular Localization
Cytoplasm,Nucleus
-
Expression
Tissue_Specificity: Ubiquitously expressed, including in the fetal brain and liver (PubMed:26752201). Expressed in brain, lung, spleen and skeletal muscle (PubMed:11313722, PubMed:12393603). Lower levels detected in heart and kidney (PubMed:11313722, PubMed:12393603). Not detected in the pancreas (PubMed:11313722). In non-lymphoid tissues, in the absence of inflammation, the major source of constitutive expression is the macrophage lineage (PubMed:12393603). Also expressed in cells from different hemopoietic cell lineages, including bone marrow cells, CD34+ stem cells, mature B- and T-cells, monocytes and granulocytes (PubMed:11313722). Down-regulated in activated macrophages from inflammatory lesions of delayed-type hypersensitivity (DTH) reactions, such as in tuberculosis and in Crohn disease, whereas in Burkitt lymphoma, persists in macrophages involved in the phagocytosis of apoptotic malignant cells (PubMed:12393603)
Induction: Induced in T-lymphocytes by IL2 deprivation -
Isoforms & Post-Translational Modification
Q99576 has three isomers: Q99576-1: 14810 Da (predicted); Q99576-3: 22213 Da (predicted); Q99576-5: 8673 Da (predicted).
-
Subunit
Can form homodimers, however it is likely to function as a monomer (By similarity)
-
SwissProt ID
-
Synonyms
DIP; DSIPI; GILZ; TSC-22R
Documentation